Greece vs Italy: Statin use vs. average non-HDL cholesterol levels

Greece
3.5
in 2018
Italy
3.5
in 2018
Greece rank
52nd
Italy rank
52nd

Statin use vs. average non-HDL cholesterol levels over time

  • Greece
  • Italy
01234198019992018

How they compare

Greece currently reports 3.5 against 3.5 in Italy, a difference of 0.

Across all 39 years both countries report, Italy has been ahead every year.

Greece ranks 52nd and Italy ranks 52nd of 191 countries.

Italy has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Greece Italy Difference Ahead
1980s 4.18 4.22 0.04 Italy
1990s 3.85 4 0.15 Italy
2000s 3.61 3.84 0.23 Italy
2010s 3.5 3.63 0.1333 Italy

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Greece or Italy?
Greece, at 3.5 against 3.5 in Italy as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Greece and Italy?
0, with Greece ahead.
How many years of comparable data are there for Greece and Italy?
39 years are reported by both, from 1980 to 2018.
How do Greece and Italy rank globally for statin use vs. average non-hdl cholesterol levels?
Greece ranks 52nd and Italy ranks 52nd of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.